IOSP (Innospec) ROCE %: 8.60% (As of Mar. 2026)

What is Innospec ROCE %?

Innospec IOSP +1.93% 76 ROCE % is 8.60% as of Mar. 2026. GuruFocus rates IOSP with a GF Score™ of 76/100 and a GF Value™ of $94.97 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Innospec's annualized ROCE % for the quarter that ended in Mar. 2026 was 8.60%.

Innospec (NAS:IOSP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Innospec ROCE % Related Terms

Innospec ROCE % Historical Data

* Premium members only.

The historical data trend for Innospec's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innospec ROCE % Chart

Innospec Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

10.95

15.40

12.76

13.42

11.02

Innospec Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															12.40	9.70	8.54	12.92	8.60

76GF Score

Innospec Inc IOSP

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Innospec ROCE % Calculation

Innospec's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	156.3	/	( ( (1734.7 - 371.4)	+	(1832.4 - 360.1) )	/ 2 )
	=	156.3	/	( (1363.3	+	1472.3)	/ 2 )
	=	156.3	/	1417.8
	=	11.02 %

Innospec's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	127.2	/	( ( (1832.4 - 360.1)	+	(1819.8 - 334.8) )	/ 2 )
	=	127.2	/	( ( 1472.3	+	1485 )	/ 2 )
	=	127.2	/	1478.65
	=	8.60 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 8.60% mean?

Innospec (IOSP) has a ROCE % of 8.60% as of Mar. 2026.

Is Innospec's ROCE % too high?

Innospec's current ROCE % is 8.60%. The Chemicals industry median ROCE % is 6.45. Innospec's value of 8.60% is 33.4% above this industry median. Overall, Innospec has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Innospec's ROCE % compare to NGVT and MTX?

Innospec's ROCE % of 8.60% can be compared against companies in the Chemicals industry. The industry median ROCE % is 6.45. Innospec's value of 8.60% is 33.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Chemicals company?

The median ROCE % among Chemicals companies is 6.45, based on 1,594 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innospec's current ROCE % of 8.60% is 33.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median ROCE % is 6.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innospec's current ROCE % is 8.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Innospec stock overvalued right now?

Based on GuruFocus' analysis, Innospec (IOSP) is currently considered Modestly Undervalued. The stock's GF Value™ is $94.97, compared to a current price of $83.44 — trading 12.1% below its estimated fair value. The current ROCE % is 8.60% and 33.4% above the Chemicals industry median of 6.45. Innospec's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Innospec (IOSP), the current ROCE % is 8.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Innospec (IOSP) Overvalued in 2026?

Based on GuruFocus' analysis, Innospec stock appears to be undervalued. The current stock price of $83.44 is trading 12.1% below its estimated GF Value™ of $94.97. GuruFocus considers Innospec to be Modestly Undervalued.

Key valuation signals for IOSP:

ROCE %: 8.60%
GF Value™: $94.97 vs. price of $83.44 (12.1% below fair value)
GF Score™: 76/100 with 3 warning signs
Industry Position: 33.4% above the Chemicals median

No single metric tells the full story. See the IOSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Innospec Business Description

Industry Basic Materials Chemicals

Comparable Companies NGVT MTX LWLG KWR ECVT ASH WDFC SCL ODC CLMT LIN XPAR:AI SHW ECL APD XSWX:GIVN SHSE:600309 XSWX:SIKA SZSE:002466 OCSE:NSIS B

Other Exchanges 0JAX:UK OCT:Germany

Address 8310 South Valley Highway, Suite 350, Englewood, CO, USA, 80112

Website https://www.innospec.com

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.

76GF Score

Get the complete analysis for IOSP

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$83.44

Price

$94.97

GF Value

View IOSP Analysis

See ROCE % data for all stocks →